Position in JNJ
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$16,125,571
+$257,260 QoQ
Shares Held
63,494
-2.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
2.32%
of 13F equity value
Holder Rank
#849
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 16%
Shared 0%
None 84%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOTH FINANCIAL ADVISORY CORP holds $48,675,880 across 11 Drug Manufacturers - General names. JNJ ranks #1 (33.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
63,494 | $16,125,571 | |
| 2 | ABBV |
AbbVie Inc.
|
59,705 | $15,024,166 | |
| 3 | AMGN |
Amgen Inc
|
28,421 | $10,291,812 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
97,037 | $5,591,271 | |
| 5 | LLY |
ELI LILLY & Co
|
1,207 | $1,447,712 | |
| 6 | PFE |
Pfizer Inc
|
4,200 | $101,136 | |
| 7 | MRK |
Merck & Co., Inc.
|
539 | $69,261 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
117 | $14,781 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,125,571 | 63,494 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $15,868,311 | 64,917 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $14,476,359 | 69,951 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $13,202,089 | 71,201 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $10,010,776 | 65,537 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $10,414,586 | 62,799 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $8,875,329 | 61,370 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $9,991,647 | 61,654 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $9,076,828 | 62,102 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $9,941,766 | 62,847 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $9,679,635 | 61,756 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $9,798,388 | 62,911 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $10,554,713 | 63,767 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $9,887,295 | 63,789 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $11,583,117 | 65,571 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $10,753,662 | 65,828 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $11,622,289 | 65,474 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $11,413,434 | 64,399 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $10,914,950 | 63,804 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $10,420,787 | 64,525 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $10,631,001 | 64,532 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $10,500,650 | 63,892 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $9,808,393 | 62,323 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $9,242,321 | 62,079 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $8,735,513 | 62,117 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $7,660,745 | 58,421 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||